Carla van Herpen

Cisplatin, Fluorouracil, and Docetaxel in Unresectable Head and Neck Cancer

Jan B. Vermorken, Éva Remenár, Carla van Herpen et al. · New England Journal of Medicine · 2007 · 1.7K citations · Full text

Medicine, Oncology, Pharmacotherapy +9

A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

Wei Jiao, Gurnit Atwal, Paz Polak et al. · Nature Communications · 2020 · 238 citations · Full text

Medicine, Genetics, Oncology +17

First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors

C. Willemien Menke‐van der Houven van Oordt, Carlos Gomez-Roca, Carla van Herpen et al. · Oncotarget · 2016 · 156 citations · Full text

Medicine, Cancer Biology, Oncology +14

Crizotinib achieves long-lasting disease control in advanced papillary renal-cell carcinoma type 1 patients with MET mutations or amplification. EORTC 90101 CREATE trial

Patrick Schöffski, Agnieszka Woźniak, Bernard Escudier et al. · European Journal of Cancer · 2017 · 115 citations

Medicine, Oncology, Pharmacology +10

Effect of Itraconazole and Rifampin on the Pharmacokinetics of Olaparib in Patients With Advanced Solid Tumors: Results of Two Phase I Open-label Studies

Luc Dirix, Helen Swaisland, Henk M.W. Verheul et al. · Clinical Therapeutics · 2016 · 57 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +7